The seizure rate associated with slow-release bupropion is lower than the seizure rate associated ...

Author Question: The seizure rate associated with slow-release bupropion is lower than the seizure rate associated ... (Read 86 times)

berenicecastro

Hero Member
Posts: 581

on: Jun 22, 2018

The seizure rate associated with slow-release bupropion is lower than the seizure rate associated with the regular-release form of bupropion.

a. True.
b. False.

Question 2

Venlafaxine appears to antagonize pre-synaptic alpha-adrenergic receptors.

a. True.
b. False.

softEldritch

Sr. Member
Posts: 334

Reply #1 on: Jun 22, 2018

Answer to Question 1

True

Answer to Question 2

False

Need homework help now?

Ask unlimited questions for free

Ask a Question

berenicecastro

Hero Member
Posts: 581

Reply #2 on: Jun 22, 2018

Thank you

softEldritch

Sr. Member
Posts: 334

Reply #3 on: Jun 22, 2018

No problem

« previous next »

Did you know?

Though methadone is often used to treat dependency on other opioids, the drug itself can be abused. Crushing or snorting methadone can achieve the opiate "rush" desired by addicts. Improper use such as these can lead to a dangerous dependency on methadone. This drug now accounts for nearly one-third of opioid-related deaths.

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

Prostaglandins were first isolated from human semen in Sweden in the 1930s. They were so named because the researcher thought that they came from the prostate gland. In fact, prostaglandins exist and are synthesized in almost every cell of the body.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.